EGFR and adenocarcinoma: However, as far as we were concerned, this study represents the first comparison study between MPP-positive adenocarcinoma and MPP-negative adenocarcinoma in EGFR exon 19 and 21 mutations of TNM stage III lung adenocarcinoma with regard to clinicopathologic characteristics and prognosis.